Skip to main content
Erschienen in: Cellular Oncology 3/2013

01.06.2013 | Original Paper

Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors

verfasst von: Barbara Patócs, Krisztina Németh, Miklós Garami, Gabriella Arató, Ilona Kovalszky, Miklós Szendrői, György Fekete

Erschienen in: Cellular Oncology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Ewing sarcoma family of tumors (EFT) is characterized by fusions of the EWSR1 gene on chromosome 22q12 with either one of the genes encoding members of the ETS family of transcription factors, in the majority of cases FLI1 or ERG. Many alternative EWSR1-ETS gene fusions have been encountered, due to variations in the locations of the EWSR1 and ETS genomic breakpoints. The resulting heterogeneity in EWSR1-ETS fusion transcripts may further be increased by the occurrence of multiple splice variants within the same tumor. Here we present a retrospective study designed to detect all of the EWSR1-FLI1 and EWSR1-ERG fusion transcripts in a series of 23 fresh frozen EFT tissues.

Methods

RT-PCR and nested fluorescent multiplex PCR were used to amplify EWSR1-FLI1 and EWSR1-ERG transcripts from EFT tissues. Fusion transcripts were identified by laser-induced fluorescent capillary electrophoresis and confirmed by sequence analysis.

Results

Nine different EWSR1-FLI1 fusion transcripts and one EWSR1-ERG fusion transcript were identified in 21 out of 23 fresh frozen EFT tissue samples. In five cases multiple fusion transcripts were found to coexist in the same tumor sample. We additionally reviewed previous reports on twelve cases with multiple EWSR1-ETS fusion transcripts.

Conclusions

Alternative splicing may frequently affect the process of EFT-associated fusion gene transcription and, as such, may significantly contribute to the pathogenic role of EFT-associated chromosome translocations. In a considerable number of cases this may result in multiple splice variants within the same tumor.
Literatur
1.
Zurück zum Zitat O. Delattre, J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, A. Aurias, G. Thomas, Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162–165 (1992)PubMedCrossRef O. Delattre, J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, A. Aurias, G. Thomas, Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162–165 (1992)PubMedCrossRef
2.
Zurück zum Zitat P.H. Sorensen, S.L. Lessnick, D. Lopez-Terrada, X.F. Liu, T.J. Triche, C.T. Denny, A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor. ERG. Nat. Genet. 6, 146–151 (1994)CrossRef P.H. Sorensen, S.L. Lessnick, D. Lopez-Terrada, X.F. Liu, T.J. Triche, C.T. Denny, A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor. ERG. Nat. Genet. 6, 146–151 (1994)CrossRef
3.
Zurück zum Zitat J. Zucman, T. Melot, C. Desmaze, J. Ghysdael, B. Plougastel, M. Peter, J.M. Zucker, T.J. Triche, D. Sheer, C. Turc-Carel, P. Ambros, V. Combaret, G. Lenoir, A. Aurias, G. Thomas, O. Delattre, Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12, 4481–4487 (1993)PubMed J. Zucman, T. Melot, C. Desmaze, J. Ghysdael, B. Plougastel, M. Peter, J.M. Zucker, T.J. Triche, D. Sheer, C. Turc-Carel, P. Ambros, V. Combaret, G. Lenoir, A. Aurias, G. Thomas, O. Delattre, Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J. 12, 4481–4487 (1993)PubMed
4.
Zurück zum Zitat J.P. Ginsberg, E. de Alava, M. Ladanyi, L.H. Wexler, H. Kovar, M. Paulussen, A. Zoubek, B. Dockhorn-Dworniczak, H. Juergens, J.S. Wunder, I.L. Andrulis, R. Malik, P.H. Sorensen, R.B. Womer, F.G. Barr, EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing’s sarcoma. J. Clin. Oncol. 17, 1809–1814 (1999)PubMed J.P. Ginsberg, E. de Alava, M. Ladanyi, L.H. Wexler, H. Kovar, M. Paulussen, A. Zoubek, B. Dockhorn-Dworniczak, H. Juergens, J.S. Wunder, I.L. Andrulis, R. Malik, P.H. Sorensen, R.B. Womer, F.G. Barr, EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing’s sarcoma. J. Clin. Oncol. 17, 1809–1814 (1999)PubMed
5.
Zurück zum Zitat M.C. Le Deley, O. Delattre, K.L. Schaefer, S.A. Burchill, G. Koehler, P.C. Hogendoorn, T. Lion, C. Poremba, J. Marandet, S. Ballet, G. Pierron, S.C. Brownhill, M. Nesslböck, A. Ranft, U. Dirksen, O. Oberlin, I.J. Lewis, A.W. Craft, H. Jürgens, H. Kovar, Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J. Clin. Oncol. 28, 1982–1988 (2010)PubMedCrossRef M.C. Le Deley, O. Delattre, K.L. Schaefer, S.A. Burchill, G. Koehler, P.C. Hogendoorn, T. Lion, C. Poremba, J. Marandet, S. Ballet, G. Pierron, S.C. Brownhill, M. Nesslböck, A. Ranft, U. Dirksen, O. Oberlin, I.J. Lewis, A.W. Craft, H. Jürgens, H. Kovar, Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J. Clin. Oncol. 28, 1982–1988 (2010)PubMedCrossRef
6.
Zurück zum Zitat C. Turc-Carel, A. Aurias, F. Mugneret, S. Lizard, I. Sidaner, C. Volk, J.P. Thiery, S. Olschwang, I. Philip, M.P. Berger, T. Philip, G.M. Lenoir, A. Mazabraud, Chromosomes in Ewing’s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32, 229–238 (1988)PubMedCrossRef C. Turc-Carel, A. Aurias, F. Mugneret, S. Lizard, I. Sidaner, C. Volk, J.P. Thiery, S. Olschwang, I. Philip, M.P. Berger, T. Philip, G.M. Lenoir, A. Mazabraud, Chromosomes in Ewing’s sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32, 229–238 (1988)PubMedCrossRef
7.
Zurück zum Zitat J.R. Downing, D.R. Head, D.M. Parham, E.C. Douglass, M.G. Hulshof, M.P. Link, T.A. Motroni, H.E. Grier, A.M. Curcio-Brint, D.N. Shapiro, Detection of the (11;22)(q24;q12) translocation of Ewing’s sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am. J. Pathol. 143, 1294–1300 (1993)PubMed J.R. Downing, D.R. Head, D.M. Parham, E.C. Douglass, M.G. Hulshof, M.P. Link, T.A. Motroni, H.E. Grier, A.M. Curcio-Brint, D.N. Shapiro, Detection of the (11;22)(q24;q12) translocation of Ewing’s sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am. J. Pathol. 143, 1294–1300 (1993)PubMed
8.
Zurück zum Zitat I.S. Jeon, J.N. Davis, B.S. Braun, J.E. Sublett, M.F. Roussel, C.T. Denny, D.N. Shapiro, A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10, 1229–1234 (1995)PubMed I.S. Jeon, J.N. Davis, B.S. Braun, J.E. Sublett, M.F. Roussel, C.T. Denny, D.N. Shapiro, A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10, 1229–1234 (1995)PubMed
9.
Zurück zum Zitat F. Urano, A. Umezawa, W. Hong, H. Kikuchi, J. Hata, A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing’s sarcoma. Biochem. Biophys. Res. Commun. 219, 608–612 (1996)PubMedCrossRef F. Urano, A. Umezawa, W. Hong, H. Kikuchi, J. Hata, A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing’s sarcoma. Biochem. Biophys. Res. Commun. 219, 608–612 (1996)PubMedCrossRef
10.
Zurück zum Zitat M. Peter, J. Couturier, H. Pacquement, J. Michon, G. Thomas, H. Magdelenat, O. Delattre, A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14, 1159–1164 (1997)PubMedCrossRef M. Peter, J. Couturier, H. Pacquement, J. Michon, G. Thomas, H. Magdelenat, O. Delattre, A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14, 1159–1164 (1997)PubMedCrossRef
11.
Zurück zum Zitat D.C. Shing, D.J. McMullan, P. Roberts, K. Smith, S.F. Chin, J. Nicholson, R.M. Tillman, P. Ramani, C. Cullinane, N. Coleman, FUS/ERG gene fusions in Ewing’s tumors. Cancer Res. 63, 4568–4576 (2003)PubMed D.C. Shing, D.J. McMullan, P. Roberts, K. Smith, S.F. Chin, J. Nicholson, R.M. Tillman, P. Ramani, C. Cullinane, N. Coleman, FUS/ERG gene fusions in Ewing’s tumors. Cancer Res. 63, 4568–4576 (2003)PubMed
12.
Zurück zum Zitat T.L. Ng, M.J. O’Sullivan, C.J. Pallen, M. Hayes, P.W. Clarkson, M. Winstanley, P.H. Sorensen, T.O. Nielsen, D.E. Horsman, Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J. Mol. Diagn. 9, 459–463 (2007)PubMedCrossRef T.L. Ng, M.J. O’Sullivan, C.J. Pallen, M. Hayes, P.W. Clarkson, M. Winstanley, P.H. Sorensen, T.O. Nielsen, D.E. Horsman, Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J. Mol. Diagn. 9, 459–463 (2007)PubMedCrossRef
13.
Zurück zum Zitat T. Mastrangelo, P. Modena, S. Tornielli, F. Bullrich, M.A. Testi, A. Mezzelani, P. Radice, A. Azzarelli, S. Pilotti, C.M. Croce, M.A. Pierotti, G. Sozzi, A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 19, 3799–3804 (2000)PubMedCrossRef T. Mastrangelo, P. Modena, S. Tornielli, F. Bullrich, M.A. Testi, A. Mezzelani, P. Radice, A. Azzarelli, S. Pilotti, C.M. Croce, M.A. Pierotti, G. Sozzi, A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 19, 3799–3804 (2000)PubMedCrossRef
14.
Zurück zum Zitat L. Wang, R. Bhargava, T. Zheng, L. Wexler, M.H. Collins, D. Roulston, M. Ladanyi, Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J. Mol. Diagn. 9, 498–509 (2007)PubMedCrossRef L. Wang, R. Bhargava, T. Zheng, L. Wexler, M.H. Collins, D. Roulston, M. Ladanyi, Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J. Mol. Diagn. 9, 498–509 (2007)PubMedCrossRef
15.
Zurück zum Zitat K. Szuhai, M. Ijszenga, D. de Jong, A. Karseladze, H.J. Tanke, P.C. Hogendoorn, The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin. Cancer Res. 15, 2259–2268 (2009)PubMedCrossRef K. Szuhai, M. Ijszenga, D. de Jong, A. Karseladze, H.J. Tanke, P.C. Hogendoorn, The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin. Cancer Res. 15, 2259–2268 (2009)PubMedCrossRef
16.
Zurück zum Zitat J. Sumegi, J. Nishio, M. Nelson, R.W. Frayer, D. Perry, J.A. Bridge, A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod. Pathol. 24, 333–342 (2011)PubMedCrossRef J. Sumegi, J. Nishio, M. Nelson, R.W. Frayer, D. Perry, J.A. Bridge, A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod. Pathol. 24, 333–342 (2011)PubMedCrossRef
17.
Zurück zum Zitat A. Zoubek, C. Pfleiderer, M. Salzer-Kuntschik, G. Amann, R. Windhager, F.M. Fink, E. Koscielniak, O. Delattre, S. Strehl, P.F. Ambros, H. Gadner, H. Kovar, Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br. J. Cancer 70, 908–913 (1994)PubMedCrossRef A. Zoubek, C. Pfleiderer, M. Salzer-Kuntschik, G. Amann, R. Windhager, F.M. Fink, E. Koscielniak, O. Delattre, S. Strehl, P.F. Ambros, H. Gadner, H. Kovar, Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br. J. Cancer 70, 908–913 (1994)PubMedCrossRef
18.
Zurück zum Zitat G. Gamberi, S. Cocchi, S. Benini, G. Magagnoli, L. Morandi, J. Kreshak, M. Gambarotti, P. Picci, L. Zanella, M. Alberghini, Molecular diagnosis in Ewing family tumors: the Rizzoli experience–222 consecutive cases in four years. J. Mol. Diagn. 13, 313–324 (2011)PubMedCrossRef G. Gamberi, S. Cocchi, S. Benini, G. Magagnoli, L. Morandi, J. Kreshak, M. Gambarotti, P. Picci, L. Zanella, M. Alberghini, Molecular diagnosis in Ewing family tumors: the Rizzoli experience–222 consecutive cases in four years. J. Mol. Diagn. 13, 313–324 (2011)PubMedCrossRef
19.
Zurück zum Zitat A. Zoubek, B. Dockhorn-Dworniczak, O. Delattre, H. Christiansen, F. Niggli, I. Gatterer-Menz, T.L. Smith, H. Jürgens, H. Gadner, H. Kovar, Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14, 1245–1251 (1996)PubMed A. Zoubek, B. Dockhorn-Dworniczak, O. Delattre, H. Christiansen, F. Niggli, I. Gatterer-Menz, T.L. Smith, H. Jürgens, H. Gadner, H. Kovar, Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14, 1245–1251 (1996)PubMed
20.
Zurück zum Zitat W.A. May, S.L. Lessnick, B.S. Braun, M. Klemsz, B.C. Lewis, L.B. Lunsford, R. Hromas, C.T. Denny, The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393–7398 (1993)PubMed W.A. May, S.L. Lessnick, B.S. Braun, M. Klemsz, B.C. Lewis, L.B. Lunsford, R. Hromas, C.T. Denny, The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393–7398 (1993)PubMed
21.
Zurück zum Zitat W.A. May, M.L. Gishizky, S.L. Lessnick, L.B. Lunsford, B.C. Lewis, O. Delattre, J. Zucman, G. Thomas, C.T. Denny, Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. U. S. A. 90, 5752–5756 (1993)PubMedCrossRef W.A. May, M.L. Gishizky, S.L. Lessnick, L.B. Lunsford, B.C. Lewis, O. Delattre, J. Zucman, G. Thomas, C.T. Denny, Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. U. S. A. 90, 5752–5756 (1993)PubMedCrossRef
22.
Zurück zum Zitat B. Patócs, K. Németh, M. Garami, G. Arató, I. Kovalszky, M. Szendrői, G. Fekete, Utilization of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues. J. Clin. Path. 65, 1112–1118 (2012)PubMedCrossRef B. Patócs, K. Németh, M. Garami, G. Arató, I. Kovalszky, M. Szendrői, G. Fekete, Utilization of fluorescent multiplex PCR and laser-induced capillary electrophoresis for the diagnosis of Ewing family of tumours in formalin-fixed paraffin-embedded tissues. J. Clin. Path. 65, 1112–1118 (2012)PubMedCrossRef
23.
Zurück zum Zitat S. Ushigome, R. Machinami, P.H. Sorensen, Ewing Sarcoma/Primitive Neuroectodermal Tumour (PNET), in World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, ed. by C.D.M. Fletcher, K.K. Unni, F. Mertens (IARC Press, Lyon, 2002), pp. 297–300 S. Ushigome, R. Machinami, P.H. Sorensen, Ewing Sarcoma/Primitive Neuroectodermal Tumour (PNET), in World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, ed. by C.D.M. Fletcher, K.K. Unni, F. Mertens (IARC Press, Lyon, 2002), pp. 297–300
24.
Zurück zum Zitat M. Giovannini, J.A. Biegel, M. Serra, J.Y. Wang, Y.H. Wei, L. Nycum, B.S. Emanuel, G.A. Evans, EWS-erg and EWS-Fli1 fusion transcripts in Ewing’s sarcoma and primitive neuroectodermal tumors with variant translocations. J. Clin. Invest. 94, 489–496 (1994)PubMedCrossRef M. Giovannini, J.A. Biegel, M. Serra, J.Y. Wang, Y.H. Wei, L. Nycum, B.S. Emanuel, G.A. Evans, EWS-erg and EWS-Fli1 fusion transcripts in Ewing’s sarcoma and primitive neuroectodermal tumors with variant translocations. J. Clin. Invest. 94, 489–496 (1994)PubMedCrossRef
25.
Zurück zum Zitat J. Zucman-Rossi, P. Legoix, J.M. Victor, B. Lopez, G. Thomas, Chromosome translocation based on illegitimate recombination in human tumors. Proc. Natl. Acad. Sci. U. S. A 95, 11786–11791 (1998)PubMedCrossRef J. Zucman-Rossi, P. Legoix, J.M. Victor, B. Lopez, G. Thomas, Chromosome translocation based on illegitimate recombination in human tumors. Proc. Natl. Acad. Sci. U. S. A 95, 11786–11791 (1998)PubMedCrossRef
26.
Zurück zum Zitat J. Liu, M.M. Nau, J.C. Yeh, C.J. Allegra, E. Chu, J.J. Wright, Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Clin. Cancer Res. 6, 3522–3529 (2000)PubMed J. Liu, M.M. Nau, J.C. Yeh, C.J. Allegra, E. Chu, J.J. Wright, Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors. Clin. Cancer Res. 6, 3522–3529 (2000)PubMed
27.
Zurück zum Zitat K. Yang, W.O. Lui, Y. Xie, A. Zhang, B. Skytting, N. Mandahl, C. Larsson, O. Larsson, Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene 21, 4181–4190 (2002)PubMedCrossRef K. Yang, W.O. Lui, Y. Xie, A. Zhang, B. Skytting, N. Mandahl, C. Larsson, O. Larsson, Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene 21, 4181–4190 (2002)PubMedCrossRef
28.
Zurück zum Zitat W.L. Wang, E. Mayordomo, W. Zhang, V.S. Hernandez, D. Tuvin, L. Garcia, D.C. Lev, A.J. Lazar, D. López-Terrada, Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod. Pathol. 22, 1201–1209 (2009)PubMedCrossRef W.L. Wang, E. Mayordomo, W. Zhang, V.S. Hernandez, D. Tuvin, L. Garcia, D.C. Lev, A.J. Lazar, D. López-Terrada, Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod. Pathol. 22, 1201–1209 (2009)PubMedCrossRef
29.
Zurück zum Zitat A. Jakubauskas, V. Valceckiene, K. Andrekute, D. Seinin, A. Kanopka, L. Griskevicius, Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation. Exp. Mol. Pathol. 90, 194–200 (2011)PubMedCrossRef A. Jakubauskas, V. Valceckiene, K. Andrekute, D. Seinin, A. Kanopka, L. Griskevicius, Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation. Exp. Mol. Pathol. 90, 194–200 (2011)PubMedCrossRef
30.
Zurück zum Zitat E. De Braekeleer, N. Douet-Guilbert, D. Rowe, N. Bown, F. Morel, C. Berthou, C. Férec, M. De Braekeleer, ABL1 fusion genes in hematological malignancies: a review. Eur. J. Haematol. 86, 361–371 (2011)PubMedCrossRef E. De Braekeleer, N. Douet-Guilbert, D. Rowe, N. Bown, F. Morel, C. Berthou, C. Férec, M. De Braekeleer, ABL1 fusion genes in hematological malignancies: a review. Eur. J. Haematol. 86, 361–371 (2011)PubMedCrossRef
31.
Zurück zum Zitat P.P. Pandolfi, M. Alcalay, M. Fagioli, D. Zangrilli, A. Mencarelli, D. Diverio, A. Biondi, F. Lo Coco, A. Rambaldi, F. Grignani, C. Rochette-Egly, M.P. Gaube, P. Chambon, P.G. Pelicci, Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J. 11, 1397–1407 (1992)PubMed P.P. Pandolfi, M. Alcalay, M. Fagioli, D. Zangrilli, A. Mencarelli, D. Diverio, A. Biondi, F. Lo Coco, A. Rambaldi, F. Grignani, C. Rochette-Egly, M.P. Gaube, P. Chambon, P.G. Pelicci, Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J. 11, 1397–1407 (1992)PubMed
32.
Zurück zum Zitat E. de Alava, A. Kawai, J.H. Healey, I. Fligman, P.A. Meyers, A.G. Huvos, W.L. Gerald, S.C. Jhanwar, P. Argani, C.R. Antonescu, F.J. Pardo-Mindan, J. Ginsberg, R. Womer, E.R. Lawlor, J. Wunder, I. Andrulis, P.H. Sorensen, F.G. Barr, M. Ladanyi, EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J. Clin. Oncol. 16, 1248–1255 (1998)PubMed E. de Alava, A. Kawai, J.H. Healey, I. Fligman, P.A. Meyers, A.G. Huvos, W.L. Gerald, S.C. Jhanwar, P. Argani, C.R. Antonescu, F.J. Pardo-Mindan, J. Ginsberg, R. Womer, E.R. Lawlor, J. Wunder, I. Andrulis, P.H. Sorensen, F.G. Barr, M. Ladanyi, EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J. Clin. Oncol. 16, 1248–1255 (1998)PubMed
33.
Zurück zum Zitat N. Yoshino, T. Kojima, S. Asami, S. Motohashi, Y. Yoshida, M. Chin, H. Shichino, Y. Yoshida, N. Nemoto, M. Kaneko, H. Mugishima, T. Suzuki, Diagnostic significance and clinical applications of chimeric genes in Ewing’s sarcoma. Biol. Pharm. Bull. 26, 585–588 (2003)PubMedCrossRef N. Yoshino, T. Kojima, S. Asami, S. Motohashi, Y. Yoshida, M. Chin, H. Shichino, Y. Yoshida, N. Nemoto, M. Kaneko, H. Mugishima, T. Suzuki, Diagnostic significance and clinical applications of chimeric genes in Ewing’s sarcoma. Biol. Pharm. Bull. 26, 585–588 (2003)PubMedCrossRef
34.
Zurück zum Zitat F. Minoletti, G. Sozzi, S. Tornielli, S. Pilotti, A. Azzarelli, M.A. Pierotti, P. Radice, A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation. J. Pathol. 186, 434–437 (1998)PubMedCrossRef F. Minoletti, G. Sozzi, S. Tornielli, S. Pilotti, A. Azzarelli, M.A. Pierotti, P. Radice, A novel EWS-ERG rearrangement generating two hybrid mRNAs in a peripheral primitive neuroectodermal tumour (pPNET) with a t(15;22) translocation. J. Pathol. 186, 434–437 (1998)PubMedCrossRef
35.
Zurück zum Zitat S.S. Bielack, M. Paulussen, G. Köhler, A patient with two Ewing’s sarcomas with distinct EWS fusion transcripts. N. Engl. J. Med. 350, 1364–1365 (2004)PubMedCrossRef S.S. Bielack, M. Paulussen, G. Köhler, A patient with two Ewing’s sarcomas with distinct EWS fusion transcripts. N. Engl. J. Med. 350, 1364–1365 (2004)PubMedCrossRef
36.
Zurück zum Zitat T.B. Lewis, C.M. Coffin, P.S. Bernard, Differentiating Ewing’s sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod. Pathol. 20, 397–404 (2007)PubMedCrossRef T.B. Lewis, C.M. Coffin, P.S. Bernard, Differentiating Ewing’s sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues. Mod. Pathol. 20, 397–404 (2007)PubMedCrossRef
37.
Zurück zum Zitat R.I. Skotheim, M. Nees, Alternative splicing in cancer: noise, functional, or systematic? Int. J. Biochem. Cell Biol. 39, 1432–1449 (2007)PubMedCrossRef R.I. Skotheim, M. Nees, Alternative splicing in cancer: noise, functional, or systematic? Int. J. Biochem. Cell Biol. 39, 1432–1449 (2007)PubMedCrossRef
38.
Zurück zum Zitat M. Roy, Q. Xu, C. Lee, Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res. 33, 5026–5033 (2005)PubMedCrossRef M. Roy, Q. Xu, C. Lee, Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Res. 33, 5026–5033 (2005)PubMedCrossRef
Metadaten
Titel
Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors
verfasst von
Barbara Patócs
Krisztina Németh
Miklós Garami
Gabriella Arató
Ilona Kovalszky
Miklós Szendrői
György Fekete
Publikationsdatum
01.06.2013
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 3/2013
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-013-0126-8

Weitere Artikel der Ausgabe 3/2013

Cellular Oncology 3/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …